Sort
64,565 grants matching “drug discovery”
Regulatory landscape of the human genome: comparative and evolutionary analysis.
$1,691,242Ivan Ovcharenko · National Library Of Medicine · ZIA · FY2024 · LM
SPORE University of Texas M. D. Anderson Cancer Center-Leukemia
$1,689,836Marina Y Konopleva · University Of Tx Md Anderson Can Ctr · P50 · FY2021 · CA
SPORE University of Texas M. D. Anderson Cancer Center-Leukemia
$1,689,836Marina Y Konopleva · University Of Tx Md Anderson Can Ctr · P50 · FY2022 · CA
Cancer Biology and Genetics
$1,689,162Harold Varmus · National Human Genome Research Institute · ZIA · FY2011 · HG
Cellular and Molecular Physiology of Bloodstream Malaria Parasites
$1,688,469Sanjay A Desai · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
The Pathogenesis, Diagnosis, and Treatment of Systemic Mast Cell Disorders
$1,688,138Hirsh D Komarow · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Direct protein phosphatase 2A (PP2A) activators as novel Alzheimerâs Disease (AD) therapeutics
$1,688,077Michael Ohlmeyer · Atux Iskay Group Llc · R44 · FY2024 · AG
Innovative technologies to transform antibiotic discovery. Project 2 Engineering antibiotic sensitization therapies
$1,687,630Paul Clark Blainey · Broad Institute, Inc. · U19 · FY2022 · AI
Chemoproteomic Identification and Therapeutic Validation of Proteins of Metabolic Significance
$1,687,337Enrique Saez · Scripps Research Institute, The · RC2 · FY2017 · DK
U.T. M. D. Anderson Cancer Center SPORE in Ovarian Cancer
$1,686,672Robert C Bast · University Of Tx Md Anderson Can Ctr · P50 · FY2021 · CA
NHLBI Bay Area Functional Genomics Consortium
$1,686,092Stephen G Young · University Of California Los Angeles · U01 · FY2007 · HL
Mechanisms, Prevention and Treatment of Chronic Graft-vs.-Host Disease
$1,685,462Corey S Cutler · Dana-Farber Cancer Inst · P01 · FY2015 · CA
Development of Orexin-1 Receptor Antagonists for Drug Addiction
$1,685,235Theodore M Kamenecka · Scripps Research Institute, The · P01 · FY2014 · DA
Targets for Therapy for Carcinomas of the Lung
$1,684,807Mark G Kris · Sloan-Kettering Inst Can Research · P01 · FY2014 · CA
Molecular Studies of Malformations
$1,684,110Leslie Biesecker · National Human Genome Research Institute · ZIA · FY2019 · HG
Emory/Atlanta Center for AIDS Research
$1,683,833James W. Curran · Emory University · P30 · FY2011 · AI
Chronic HIV infection and Aging in NeuroAIDS (CHAIN) Center
$1,683,828Howard S. Fox · University Of Nebraska Medical Center · P30 · FY2014 · MH
Transcriptional Mechanisms of Drug Addiction
$1,683,245Eric J Nestler · Icahn School Of Medicine At Mount Sinai · P01 · FY2024 · DA
ANCA Glomerulonephritis: From Molecules to Man
$1,683,140Ronald J Falk · Univ Of North Carolina Chapel Hill · P01 · FY2018 · DK
Lens β-Amyloid Biomarker for Early Detection of Preclinical Alzheimer's Disease in the Framingham Study
$1,682,982Lee E Goldstein · Boston University Medical Campus · RF1 · FY2021 · AG
Vaso-Hormonal Mechanisms in Hypertension
$1,682,622Carlos M Ferrario · Wake Forest University Health Sciences · P01 · FY2019 · HL
Development of Pre-Erythrocytic Malaria Vaccines
$1,680,701Robert A Seder · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
NCI-Frederick Support and Technical Services
$1,678,647Kristin Komschlies McConville · Office Of The Director, Nci · ZIC · FY2025 · CA
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
$1,677,941Suresh Ambudkar · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Cardiovascular Genomics and Bioinformatics projects
$1,677,588Andrew Johnson · National Heart, Lung, And Blood Institute · ZIA · FY2019 · HL